Results 1-20 of 4,221 for speaker:Pádraig O'Sullivan

Ceisteanna Eile - Other Questions: Cybersecurity Policy (6 Nov 2025)

Pádraig O'Sullivan: 9. To ask the Taoiseach and Minister for Defence the measures being taken to strengthen our cyber defence capabilities; and if he will make a statement on the matter. [59446/25]

International Protection Processing and Enforcement: Statements (5 Nov 2025)

Pádraig O'Sullivan: I express my condemnation of the appalling attack that took place at the IPAS centre in Drogheda last week. Such acts of violence are unacceptable and have no place in any society. My thoughts are with all of those affected. This is such an important and sensitive issue. I fully recognise the need for a robust international protection system for people fleeing war-torn regions. The...

Ceisteanna ar Pholasaí nó ar Reachtaíocht - Questions on Policy or Legislation (5 Nov 2025)

Pádraig O'Sullivan: Budget 2026 allocated €117 billion nationwide. Approximately €19 billion or €20 billion of that was in capital investment. I raise with the Minister the issue of Carrignavar wastewater treatment plant. It is something that has been highlighted and identified as in need of urgent investment from Irish Water and Cork County Council. Nonetheless, it has been waiting...

Ceisteanna Eile - Other Questions: Special Educational Needs (4 Nov 2025)

Pádraig O'Sullivan: 8. To ask the Minister for Education and Skills for an update on staffing issues in a school (details supplied) in County Cork; and if she will make a statement on the matter. [58318/25]

Ceisteanna Eile - Other Questions: Special Educational Needs (4 Nov 2025)

Pádraig O'Sullivan: I did not hear what the Minister of State said at the outset. Initially, there were nine special educational needs, SEN, teachers and 18 SNAs. The Minister of State said there was an additional SEN teacher. How many SNAs?

Ceisteanna Eile - Other Questions: Special Educational Needs (4 Nov 2025)

Pádraig O'Sullivan: Are they recent additions?

Ceisteanna Eile - Other Questions: Special Educational Needs (4 Nov 2025)

Pádraig O'Sullivan: The Minister of State said that the Department is in contact with the school on an ongoing basis. Has the review that was instigated upon the arrival of officials from the NCSE and the Department concluded in the school? Is there any prospect of additional resources or has it been deemed that the resources provided heretofore are sufficient? As the Minister of State said, St....

Ceisteanna Eile - Other Questions: Special Educational Needs (4 Nov 2025)

Pádraig O'Sullivan: I genuinely acknowledge the Minister of State’s involvement in this. I rang him on Thursday night, when this story was about to break, and he got straight on to the school the following morning. That was appreciated by the parents and the school management. I seek clarification on one or two more points. The Minister of State said the NCSE is due to follow up this week. I...

Joint Oireachtas Committee on Health: Current Issues Relating to Health Services for Cancer: Discussion (22 Oct 2025)

Pádraig O'Sullivan: I would like to talk about that groundbreaking progress. Let us be straight about it - quite a lot of new cancer drugs are orphan drugs. We do not have any separate reimbursement process for those drugs. Is a separate pathway something the Government and the Minister should be looking at?

Joint Oireachtas Committee on Health: Current Issues Relating to Health Services for Cancer: Discussion (22 Oct 2025)

Pádraig O'Sullivan: I am not trying to put words in Dr. McCarthy's mouth but he said we have a "robust" process here. Does he mean get we very good value for money or is the process lengthy and complex? What did he mean by robustness?

Joint Oireachtas Committee on Health: Current Issues Relating to Health Services for Cancer: Discussion (22 Oct 2025)

Pádraig O'Sullivan: I have spent all my time talking about drugs; apologies for that. I might come back if there is more time later. On clinical trials in the Irish Cancer Society's submission, what is the genuine fear? I assume the society deals with pharmaceutical companies and industry the whole time. What is the genuine concern they express to the society in relation to attracting clinical trials to Ireland?

Joint Oireachtas Committee on Health: Current Issues Relating to Health Services for Cancer: Discussion (22 Oct 2025)

Pádraig O'Sullivan: I welcome everyone this morning. I will stick to what I spoke to the Irish Cancer Society about previously, particularly the area of drugs and reimbursement. I have been on this train for a while when it comes to raising this issue. First, I acknowledge there has been progress in recent years. While we are getting money allocated to new drugs, the process of reimbursing drugs,...

Joint Oireachtas Committee on Health: Current Issues Relating to Health Services for Cancer: Discussion (22 Oct 2025)

Pádraig O'Sullivan: I am talking about the process itself, not the transparency issue because we should be doing that anyway. We do not need Mazars to tell us that, to be fair. Is the reimbursement process effective, efficient, timely and patient-centred?

Joint Oireachtas Committee on Health: Current Issues Relating to Health Services for Cancer: Discussion (22 Oct 2025)

Pádraig O'Sullivan: I am sorry to interrupt Professor Ó Laoide. Over the years, I have seen a number of presentations such as the one given to us today. We are making comparisons this morning with Denmark, which has a similar size economy and population, but is dramatically better, faster and more efficient at getting drugs and treatments to patients. Where are we going wrong?

Joint Oireachtas Committee on Health: Current Issues Relating to Health Services for Cancer: Discussion (22 Oct 2025)

Pádraig O'Sullivan: Is the market here any different from the market in Denmark in terms of patient cohorts? I assume they are similar.

Joint Oireachtas Committee on Health: Current Issues Relating to Health Services for Cancer: Discussion (22 Oct 2025)

Pádraig O'Sullivan: So it is the process, rather than-----

Joint Oireachtas Committee on Health: Current Issues Relating to Health Services for Cancer: Discussion (22 Oct 2025)

Pádraig O'Sullivan: I am sorry to be pushy but I am watching the clock. With regard to the early access programme, the Minister, Deputy Carroll MacNeill, said on the record that she is looking at this. Thank God that, after many years, she is looking at it. Where does the HSE stand in that regard? How does it envisage its roll-out? I know it is very tentative at the moment.

Joint Oireachtas Committee on Health: Current Issues Relating to Health Services for Cancer: Discussion (22 Oct 2025)

Pádraig O'Sullivan: Professor Ó Laoide was right to acknowledge at the start that there are myriad of reasons for the delays. It is not just the public side. Sometimes, it is the industry and the negotiation piece.

Joint Oireachtas Committee on Health: Current Issues Relating to Health Services for Cancer: Discussion (22 Oct 2025)

Pádraig O'Sullivan: Yes. Professor Michael Barry told us that last week, to be fair. Do the witnesses feel that the one-size-fits-all approach to the reimbursement process is working, notwithstanding the time issue? Is it suitable to put all the drugs in that process or should we have something more bespoke?

Joint Oireachtas Committee on Health: Current Issues Relating to Health Services for Cancer: Discussion (22 Oct 2025)

Pádraig O'Sullivan: Take the quality threshold as an example, which we debated last week. No rare disease drug is going to meet that quality threshold. Last week, Professor Barry said that one such drug met that threshold in the past year. To take that example by itself, what do the witnesses think of that process?